Clinical trial
Surveillance of Metabolic Parameters in Patients Who Will Receive Chemotherapy After Surgical Resection of Colorectal Cancer: KBSMC Colon Cancer Cohort
NCT02700555 is registered in ClinicalTrials.gov with Kangbuk Samsung Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Surveillance of Metabolic Parameters in Patients Who Will Receive Chemotherapy After Surgical Resection of Colorectal Cancer: KBSMC Colon Cancer Cohort
- Lead sponsor
- Kangbuk Samsung Hospital
- Phase
- Observational
- Overall status
- Terminated
- Start date
- February 29, 2016
- Completion date
- February 29, 2020
- Enrollment
- 23 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
colorectal cancer